Significantly more people with mental illness and substance use disorders had insurance coverage in 2014 due to the expansion of health insurance under the Affordable Care Act (ACA), but many barriers to treatment remain, new Johns Hopkins Bloomberg School of Public Health research suggests.
People who use cocaine regularly are at high risk of coronary artery disease. A study in the Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine (ASAM), reports that stopping or reducing cocaine use can potentially reverse the process of coronary atherosclerosis. The journal is published by Wolters Kluwer.
In Colorado and other states, establishing specialized controlled substances pharmacies is proving to be a workable and practical solution to help prevent medication abuse and assure that legitimate pain patients will continue to receive the medication they need.
In a survey of almost 2,000 people who said they had had a past negative experience when taking psilocybin-containing "magic mushrooms," Johns Hopkins researchers say that more than 10 percent believed their worst "bad trip" had put themselves or others in harm's way, and a substantial majority called their most distressing episode one of the top 10 biggest challenges of their lives.
A new Northwestern Medicine study offers a bleak assessment in a rare look at the outcomes of delinquent youth five and 12 years after juvenile detention. Central to poor outcomes for the youth post detention are stark and persistent racial, ethnic and gender disparities, according to the massive study that began in the mid-1990s.
Identifies key findings of the Federation of State Medical Board's 2016 State Medical Board Survey. Telemedicine, opioid prescribing, the Interstate Medical Licensure Compact (IMLC), physician reentry into practice and medical marijuana were found to be the top five most important regulatory topics to state medical boards in 2016.
The Addiction Medicine Foundation today announced the accreditation of two additional fellowship programs to train addiction medicine physicians. The Foundation has supported the establishment of 44 addiction medicine fellowship training programs to date, based at major medical schools and teaching hospitals across North America, and is committed to establishing a total of 125 Accreditation Council for Graduate Medical Education-accredited addiction medicine fellowship programs by 2025.
Residential “in-patient” treatment for substance abuse is a preferred option for those seeking to recover. However, relapse within the first year following discharge ranges from 37% to 56%. Engagement in aftercare improves this statistic; only about half use outpatient care, and even fewer stick with it. Researchers explored the factors that hinder and help individuals transition from long-term residential substance abuse treatment centers to the community.
For the first time, researchers have determined the potential cost and benefits of opening a supervised injection facility for people who inject drugs in the United States. The study, released today, found that a single facility in San Francisco could generate $3.5 million in savings.
In a paper published online Dec. 7 in the Proceedings of the National Academy of Sciences, University of Washington researchers report on a statistical approach called "tree bootstrapping" can help social scientists study hard-to-reach populations like drug users.
Researchers have created a microfluidic device that could lead to faster, more sophisticated, and lower cost methods for screening drugs for liver toxicity – before the drugs are moved into human trials.
Teenagers' use of drugs, alcohol and tobacco declined significantly in 2016 at rates that are at their lowest since the 1990s, a new national study showed.
The number of babies born with drug withdrawal symptoms from opioids grew substantially faster in rural communities than in cities, a new study suggests.
While the daily dose of methadone for opiate addiction has declined in recent years, facilities run by African-American directors were more likely to provide low methadone doses than facilities run by managers of other races and ethnicities.
Researchers at Indiana University's Biocomplexity Institute have developed a virtual model of the human liver to better understand how the organ metabolizes acetaminophen, a common non-prescription painkiller and fever-reducer used in over-the-counter drugs such as Tylenol. The software could be used to help reduce the risk of liver failure and overdose death in this and other drugs.
More than 1,000 medications, with acetaminophen being the most common, have been associated with drug-induced liver injury (DILI). An article in AACN Advanced Critical Care discusses the clinical impact of DILI and reviews the medications that most frequently cause it.
Scientists at The Scripps Research Institute (TSRI) have developed a vaccine that blocks the pain-numbing effects of the opioid drugs oxycodone (oxy) and hydrocodone (hydro) in animal models.
Stefan Kertesz, M.D., says a better understanding of what caused and what sustains the opioid epidemic is needed among policymakers and physicians to best serve patients and address the crisis.
A Case Western Reserve University School of Medicine researcher has found that addiction treatment results improved when teens in a residential program stopped smoking.
Research from the University at Buffalo Research Institute on Addictions suggests the approach to preventing alcohol and drug use by some adolescents should begin in early childhood.
Siblings bear responsibility for the spread of problem behaviors. Identifying the exact nature of that influence has proven difficult, because behavior problems in siblings can also be traced to friends, shared genetics and shared experiences with parents. Evidence describing how problem behaviors spread between siblings has been scarce – until now, thanks to a first-of-its-kind longitudinal study on identical and fraternal twins.
Mothers in therapy for drug and alcohol use recover faster if their children take part in their treatment sessions, according to a first-of-its-kind study.
Children who are sexually abused are nearly five times more likely to inject drugs in adulthood as those who are not — while children who witness violence are about three times more likely — according to new research released today at the American Public Health Association’s 2016 Annual Meeting and Expo in Denver.
– A new paper in Biological Psychiatry reports that chronic cannabis users have reduced levels of an enzyme called fatty acid amide hydrolase (FAAH). The enzyme has been considered for treatment for cannabis dependence because it breaks down substances made in the brain that have cannabis-like effects, called endocannabinoids, rendering them inactive.
This is the first quantitative study of business manager encounters with drug use which suggests overdose recognition and naloxone training, combined with the operation of supervised injection facilities, could save lives.
Research from the University at Buffalo Research Institute on Addictions has found the abuse of prescription drugs by college students can play a role in negative sexual events such as sexual assault and regretted sex.
Bringing the world one step closer to when destructive addiction-fueling memories can be erased with a single treatment, scientists from the Florida campus of The Scripps Research Institute have received a National Institutes of Health grant through the Blueprint Neurotherapeutics Network and the National Institute of Drug Abuse.
A team led by Wayne State University School of Medicine researcher Mark Greenwald, Ph.D., will use a four-year, $2,279,723 competitively renewed grant from the National Institute on Drug Abuse (NIDA) of the National Institutes of Health to explore whether the opioid addiction treatment medication buprenorphine can decrease the magnitude and/or duration of responses to stressors faced by recovering addicts.
The results of the study could reveal a new therapeutic feature of the drug, possibly helping drug-abstinent individuals avoid relapse.
Researchers at Columbia University’s Mailman School of Public Health found that, from 2002 to 2014, there was an increase in the probability of having a prescription opioid use disorder among young adults using prescription opioids for non medical purposes.
In an important discovery in the battle against the United States’ growing drug epidemic, a Michigan State University economist has found the Carolinas could be a hotspot for the trafficking and production of the drug Ecstasy.
The DC Center for Rational Prescribing (DCRx) today announced the availability of two new online education courses aimed at teaching doctors and other healthcare professionals some of the myths and facts surrounding the use of prescription opioid painkillers. The information in the online videos could help curb the epidemic of opioid-related deaths by reducing unnecessary prescriptions—and offers valuable advice on how to wean patients from these addictive drugs.
The Urgent Care Association of America (UCAOA) and the Antibiotic Resistance Action Center (ARAC) at the Milken Institute School of Public Health at George Washington University announced today that they are entering into a three-year partnership to make the urgent care industry a leader in antibiotic stewardship by reducing inappropriate antibiotic use in this outpatient setting — action that could help slow the growing threat of antibiotic resistance.
The holistic approach to patient care and pain management used by Certified Registered Nurse Anesthetists (CRNAs) can help prevent opioid dependency, substance use disorder, drug overdoses and death, according to the American Association of Nurse Anesthetists (AANA).
A UAB-crowdfunded study to provide naloxone kits to family and friends of at-risk opioid users has distributed more than 100 kits and has seen nine overdose reversals since it began in November 2015.
A study led by researchers from the Department of Psychiatry at the University of Pittsburgh School of Medicine and Pitt Department of Psychology has identified a possible link between adolescent sleep habits and early substance abuse. The study, published today in the journal Drug and Alcohol Dependence, found that both sleep duration and sleep quality during late childhood predict alcohol and cannabis use later in adolescence.
Novel Psychoactive Substances are synthetic or “designer” drugs which have increased in popularity in recent years. Few studies in the U.S. have focused on use among one of the highest-risk populations—electronic dance music (EDM) nightclub and festival attendees. Researchers from NYU and Kings College found that more frequent nightclub attendance was strongly associated with increased risk of use of new street drugs. Attending nightclubs every week more than doubled the odds of reporting use.
What effects have prohibitionist policies had on drug consumption, incarceration and violence, particularly in the United States and in Latin America?
What are the regulatory alternatives in the Americas for marijuana—both for medical and personal use in countries like Canada, Colombia, the U.S. and Uruguay?
The O’Neill Institute for National and Global Health Law and the Center for the Advancement of the Rule of Law in the Americas host a one-day symposium to explore these questions with experts from countries in the Americas discussing the regulatory, public health, social justice and security issues that marijuana prohibition and reform face.
Interview opportunities for reporters covering key healthcare issues affecting military veteran and/or civilian patients, and the anesthesia/healthcare providers who care for them.